172 related articles for article (PubMed ID: 36562635)
1. Diagnosis and management of basal cell carcinoma: interdisciplinary consensus statements of Jose R. Reyes Memorial Medical Center, a Department of Health Tertiary Hospital in Manila, Philippines.
Ligeralde-Bascones KI; Gulmatico-Flores Z; Lim-Bueser HG; Espinoza-Thaebtharm A; Rescober-Valencia MC; Aguila KP; Anupol EBJ; Balete SL; Barcelona MV; Castro VCS; Fineza-Dela Cruz AMB; Lansangan PP; Manrique AMB; Olitoquit KD; Ortiz ACG; Palisoc ED; Santos DGV; See MRV; Sy AJF; Sy GC; Tana MG; Tayag JJS; Teo HMT
Int J Dermatol; 2023 Jun; 62(6):812-821. PubMed ID: 36562635
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.
Peris K; Fargnoli MC; Garbe C; Kaufmann R; Bastholt L; Seguin NB; Bataille V; Marmol VD; Dummer R; Harwood CA; Hauschild A; Höller C; Haedersdal M; Malvehy J; Middleton MR; Morton CA; Nagore E; Stratigos AJ; Szeimies RM; Tagliaferri L; Trakatelli M; Zalaudek I; Eggermont A; Grob JJ;
Eur J Cancer; 2019 Sep; 118():10-34. PubMed ID: 31288208
[TBL] [Abstract][Full Text] [Related]
3. Interventions for basal cell carcinoma of the skin.
Thomson J; Hogan S; Leonardi-Bee J; Williams HC; Bath-Hextall FJ
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003412. PubMed ID: 33202063
[TBL] [Abstract][Full Text] [Related]
4. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
5. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption.
Rogers HW; Coldiron BM
J Am Acad Dermatol; 2009 Jul; 61(1):96-103. PubMed ID: 19539843
[TBL] [Abstract][Full Text] [Related]
6. Basal cell carcinoma: an evidence-based treatment update.
Clark CM; Furniss M; Mackay-Wiggan JM
Am J Clin Dermatol; 2014 Jul; 15(3):197-216. PubMed ID: 24733429
[TBL] [Abstract][Full Text] [Related]
7. Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases.
Thissen MR; Kuijpers DI; Krekels GA
J Drugs Dermatol; 2006 May; 5(5):461-4. PubMed ID: 16703785
[TBL] [Abstract][Full Text] [Related]
8. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023.
Peris K; Fargnoli MC; Kaufmann R; Arenberger P; Bastholt L; Seguin NB; Bataille V; Brochez L; Del Marmol V; Dummer R; Forsea AM; Gaudy-Marqueste C; Harwood CA; Hauschild A; Höller C; Kandolf L; Kellerners-Smeets NWJ; Lallas A; Leiter U; Malvehy J; Marinović B; Mijuskovic Z; Moreno-Ramirez D; Nagore E; Nathan P; Stratigos AJ; Stockfleth E; Tagliaferri L; Trakatelli M; Vieira R; Zalaudek I; Garbe C;
Eur J Cancer; 2023 Oct; 192():113254. PubMed ID: 37604067
[TBL] [Abstract][Full Text] [Related]
9. A Review on Imiquimod Therapy and Discussion on Optimal Management of Basal Cell Carcinomas.
Kamath P; Darwin E; Arora H; Nouri K
Clin Drug Investig; 2018 Oct; 38(10):883-899. PubMed ID: 30128748
[TBL] [Abstract][Full Text] [Related]
10. Current modalities and new advances in the treatment of basal cell carcinoma.
Ceilley RI; Del Rosso JQ
Int J Dermatol; 2006 May; 45(5):489-98. PubMed ID: 16700779
[TBL] [Abstract][Full Text] [Related]
11. [What is new in basal cell carcinoma?].
Heppt M; von Braunmühl T; Berking C
Hautarzt; 2016 Nov; 67(11):876-883. PubMed ID: 27654826
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Management of Basal Cell Carcinoma.
Tanese K
Curr Treat Options Oncol; 2019 Feb; 20(2):13. PubMed ID: 30741348
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic Diagnosis.
Sohn GK; Keniston K; Kannan S; Hinds B; Jiang SIB
J Drugs Dermatol; 2021 Mar; 20(3):283-288. PubMed ID: 33683071
[TBL] [Abstract][Full Text] [Related]
14. Topical Fluorouracil Therapy for Residual Superficial Basal Cell Carcinoma Following Mohs Micrographic Surgery.
Pederson H; Staples CJ; Housewright C
J Drugs Dermatol; 2020 May; 19(5):485-486. PubMed ID: 32484617
[TBL] [Abstract][Full Text] [Related]
15. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study.
Lim GF; Perez OA; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2022 Jun; 86(6):1309-1317. PubMed ID: 35231546
[TBL] [Abstract][Full Text] [Related]
16. Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study.
van der Geer S; Martens J; van Roij J; Brand E; Ostertag JU; Verhaegh ME; Neumann HA; Krekels GA
Br J Dermatol; 2012 Jul; 167(1):110-5. PubMed ID: 22385074
[TBL] [Abstract][Full Text] [Related]
17. Basal Cell Carcinoma.
Heath MS; Bar A
Dermatol Clin; 2023 Jan; 41(1):13-21. PubMed ID: 36410973
[TBL] [Abstract][Full Text] [Related]
18. Basal cell carcinoma margin delineation: is curettage useful? A surgical and histological study.
Dika E; Fanti PA; Ismaili A; Misciali C; Vaccari S; Barisani A; Patrizi A
J Dermatolog Treat; 2013 Jun; 24(3):238-42. PubMed ID: 23216407
[TBL] [Abstract][Full Text] [Related]
19. Management of periocular basal cell carcinoma by Mohs micrographic surgery.
Litwin AS; Rytina E; Ha T; René C; Woodruff SA
J Dermatolog Treat; 2013 Jun; 24(3):232-4. PubMed ID: 22551161
[TBL] [Abstract][Full Text] [Related]
20. Variations in clinical presentation of basal cell carcinoma.
Buljan M; Bulat V; Situm M; Mihić LL; Stanić-Duktaj S
Acta Clin Croat; 2008 Mar; 47(1):25-30. PubMed ID: 18714644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
